Therefore, further randomized controlled trials with long-term follow-ups correlating and confirming the association of prognostic bio-marker (CD-31, CD34 and α-SMA) expression with behavior and prognosis of oral squamous cell carcinomas are recommended. Here, PECAM1 is linked to oral cavity squamous cell carcinoma.